Juliette Audet's most recent trade in NewAmsterdam Pharma Company NV was a trade of 30,000 Option (right to buy) done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NewAmsterdam Pharma Compan... | Juliette Audet | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 30,000 | 30,000 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Compan... | Juliette Audet | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 14,000 | 15,104 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Compan... | Juliette Audet | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 100,000 | 100,000 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Compan... | Juliette Audet | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 15.70 per share. | 26 Sep 2024 | 1,104 | 1,104 | - | 15.7 | 17,333 | Ordinary Shares |
| NewAmsterdam Pharma Compan... | Juliette Audet | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 250,000 | 250,000 | - | - | Option (right to buy) |